A Phase IV Open Label Study of the Effects of a Five Minute Infusion Time for Ethyol (Amifostine) in Patients Undergoing Chemotherapy
OBJECTIVES: I. Determine the feasibility and tolerability of administering amifostine by
intravenous infusion over 5 minutes in cancer patients undergoing chemotherapy.
OUTLINE: This is an open label, controlled study. Patients receive intravenous amifostine
over 5 minutes 30 minutes prior to chemotherapy. Patients are followed for one month post
PROJECTED ACCRUAL: A total of 20 patients will be accrued for this study.
Primary Purpose: Supportive Care
Edward H. Kaplan, MD
Rush North Shore Medical Center
United States: Federal Government
|Rush North Shore Medical Center||Skokie, Illinois 60076|